packageCanagliflozin

canagliflozin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Canagliflozin is an anti-diabetic medicine used to treat type 2 diabetes mellitus. It is an approved SGLT2 inhibitor and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q5030940 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:canagliflozin
ATC codes:A10BK02
DrugBank:DB08907
PubChem CID:24812758
ChEBI:73274
Wikidata:Q5030940
formula:C24H25FO5S
molar mass:444.517 g/mol (PubChem CID 24812758)
logP:3.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown